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Summary
 
Mice with X-linked chronic granulomatous disease (CGD) generated by targeted disruption of
 
the gp91
 
phox
 
 subunit of the NADPH–oxidase complex (X-CGD mice) were examined for their
response to respiratory challenge with 
 
Aspergillus fumigatus.
 
 This opportunistic fungal pathogen
causes infection in CGD patients due to the deficient generation of neutrophil respiratory burst
oxidants important for damaging 
 
A. fumigatus
 
 hyphae. Alveolar macrophages from X-CGD
mice were found to kill 
 
A. fumigatus
 
 conidia in vitro as effectively as alveolar macrophages from
wild-type mice. Pulmonary disease in X-CGD mice was observed after administration of doses
ranging from 10
 
5
 
 to 48 spores, none of which produced disease in wild-type mice. Higher
doses produced a rapidly fatal bronchopneumonia in X-CGD mice, whereas progression of
disease was slower at lower doses, with development of chronic inflammatory lesions. Marked
differences were also observed in the response of X-CGD mice to the administration of steril-
ized 
 
Aspergillus
 
 hyphae into the lung. Within 24 hours of administration, X-CGD mice had
significantly higher numbers of alveolar neutrophils and increased expression of the proinflam-
matory cytokines IL-1
 
b
 
 and TNF-
 
a
 
 relative to the responses seen in wild-type mice. By one
week after administration, pulmonary inflammation was resolving in wild-type mice, whereas
X-CGD mice developed chronic granulomatous lesions that persisted for at least six weeks.
This is the first experimental evidence that chronic inflammation in CGD does not always re-
sult from persistent infection, and suggests that the clinical manifestations of this disorder reflect
both impaired microbial killing as well as other abnormalities in the inflammatory response in
the absence of a respiratory burst.
 
C
 
hronic granulomatous disease (CGD)
 
1
 
 is an inherited
disorder caused by defects in the phagocyte respira-
tory burst oxidase (NADPH oxidase) which generates
superoxide (1), the precursor to hydrogen peroxide and
other reactive oxygen derivatives with microbicidal activ-
ity. Hence, patients with CGD lack an essential host anti-
microbial pathway, and develop recurrent and often severe
bacterial and fungal infections. A second and distinctive
feature of CGD is the frequent occurrence of inflammatory
granulomas in lung, liver, skin, lymph nodes, or the lining
of the gastrointestinal and genitourinary tracts (2–5). These
chronic inflammatory lesions in some cases represent an at-
tempt to contain an active site of infection, but can also be
sterile, suggesting that their formation may be due to in-
complete degradation of debris, impaired resolution of in-
flammation, or both (4, 6).
 
Aspergillus fumigatus
 
 is an opportunistic fungal pathogen
that is an important cause of pulmonary and other infec-
tions in immunocompromised hosts, including patients with
CGD. 
 
A. fumigatus
 
 exposure typically occurs via inhalation
of conidia into the respiratory tract, where resistance to
infection is twofold. Resident alveolar macrophages ingest
and kill resting conidia, largely through nonoxidative mech-
anisms, while neutrophils use oxygen-dependent mecha-
nisms to attack hyphae germinating from conidia that es-
cape macrophage surveillance (7). The effectiveness of this
system is evident from the observation that challenge with
even large numbers of conidia fail to cause disease in immu-
 
1
 
Abbreviations used in this paper:
 
 cfu, colony-forming units; CGD, chronic
granulomatous disease.
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nocompetent animals (8). To cause disease, animals must be
immunosuppressed either through the use of agents that
impair the function of resident alveolar macrophages, such
as glucocorticoids (7, 9), or those that produce profound
granulocytopenia, such as cyclophosphamide or whole-
body irradiation (7, 10).
The importance of the phagocyte respiratory burst in re-
sistance to 
 
A. fumigatus
 
 has been established by the frequent
occurrence of 
 
A. fumigatus
 
 infection in patients with CGD
(4), which appears to result largely from a failure to kill hy-
phae by neutrophil oxidative mechanisms. Although puri-
fied cationic granule proteins isolated from human neutro-
phils are able to damage hyphae in a cell-free assay system,
neutrophils from CGD patients do not cause significant
damage in vitro (11), suggesting that under physiologic
conditions, cellular nonoxidative mechanisms alone are in-
sufficient to kill hyphae. Hydrogen peroxide, a product of
the respiratory burst, has potent antihyphal activity in vitro
(11), while neutrophil-mediated hyphal damage is strongly
blocked by myeloperoxidase inhibitors, the hydrogen per-
oxide scavenger, catalase, and to a lesser extent, superoxide
dismutase (12).
The role of oxidants in resistance to the conidial form of
 
Aspergillus
 
 is probably less critical. Schaffner and others have
reported that alveolar macrophages kill 
 
Aspergillus
 
 conidia
effectively under anaerobic conditions, and that peripheral
blood monocytes from patients with CGD kill conidia as
effectively as monocytes from normal individuals (13). How-
ever, in a study suggesting that respiratory burst oxidants
may play some role in the macrophage anticonidial activity,
Washburn et al. reported that monocytes from CGD pa-
tients killed only about half as many conidia as normal
monocytes within 2 h of phagocytosis. In addition, the an-
ticonidial activity of normal monocytes was partially inhib-
ited by catalase, suggesting that oxidative mechanisms con-
tribute to macrophage anticonidial activity (14). No data
have been published regarding the anticonidial potential of
alveolar macrophages from CGD patients.
We have previously reported that X-CGD mice, gener-
ated by targeted disruption of the gp91
 
phox
 
 subunit of the
NADPH-oxidase, exhibit impaired clearance of 
 
Staphylo-
coccus aureus
 
 and 
 
A. fumigatus
 
, two common pathogens in
human CGD (15). Respiratory challenge with 
 
A. fumigatus
 
was associated with high rates of mortality in X-CGD
mice, demonstrating a requirement for phagocyte-gener-
ated oxidants in murine host resistance to 
 
Aspergillus
 
 infec-
tion. The dose of conidia used in the previous study (3 
 
3
 
10
 
6
 
/mouse) is likely to far exceed normal levels of exposure
(16, 17), probably contributing to the rapid progression of
disease and early mortality observed.
In the present study, we have investigated the response
to 
 
A. fumigatus
 
 at exposures that may be more representa-
tive of naturally occurring infection. Although alveolar
macrophages from X-CGD mice were found to kill 
 
A. fu-
migatus
 
 conidia as effectively as normal macrophages, expo-
sure to even very small numbers of conidia still resulted in
bronchopneumonia, with persistence of viable 
 
A. fumigatus
 
for at least 2–3 wk after respiratory challenge. Extensive ar-
eas of lung inflammation were often seen in X-CGD mice,
with few detectable hyphae. Remarkably, administration of
sterilized hyphal preparations also produced a chronic bron-
chopneumonia with a distinctive neutrophilic and granulo-
matous infiltrate in X-CGD mice but not wild-type mice.
The early phase of the inflammatory response in X-CGD
mice was associated with significantly higher numbers of
alveolar neutrophils and increased levels of expression of
IL-1
 
b
 
 and TNF-
 
a
 
 mRNA relative to wild-type mice. These
data suggest that the absence of respiratory burst oxidants
can result in altered progression of lung injury even to ster-
ilized 
 
Aspergillus
 
 products, which may contribute to the de-
velopment of chronic inflammatory lesions in CGD.
 
Materials and Methods
 
Animals.
 
X-CGD mice had previously been generated by
targeted disruption of the gene encoding gp91
 
phox
 
, the large
subunit of the NADPH respiratory burst oxidase complex (15).
Phagocytes from these mice are unable to generate superoxide as
measured by both the nitroblue tetrazolium test and cytochrome
c reduction assays. Mice were housed in microisolator cages un-
der specific pathogen-free conditions and fed autoclaved food and
acidified water ad libitum. For experiments involving X-CGD
mice generated by backcrossing carrier females with C57Bl/6J
males for generations up to N
 
7
 
, wild-type littermates from the
same backcross generation were used to minimize any potential
bias contributed by differences in original 129-SV 
 
3
 
 C57Bl/6J
genetic backgrounds. For experiments after generation N
 
7
 
, age-
matched wild-type C57Bl/6J mice were used. Mice studied in
these experiments were from 6 to 10 wk old.
 
Isolation and Preparation of Aspergillus Inocula.
 
A clinical isolate
of 
 
A. fumigatus
 
 (ATCC No. 90240; American Type Culture Col-
lection, Rockville, MD) was cultured on Sabouraud dextrose
agar (Becton Dickinson Labware, Lincoln Park, NJ) for 4 d at
room temperature before use. Conidia were removed by flooding
the culture dish with 5–10 ml of sterile PBS and gently scraping
the mycelia with a sterile razor blade. Suspensions consisting
mostly of single conidia were prepared by vortexing the mixture
vigorously for 1 min followed by filtration through three-ply cot-
ton gauze. Conidia were quantitated using a hemocytometer and
diluted to the appropriate concentration in PBS. Quantitation
was confirmed by plate culture of serial dilutions on Sabouraud
dextrose agar. Conidia suspensions were always used on the day
of harvest and kept on ice until needed. Viability as determined
by quantitative culture was typically 
 
.
 
95%.
 
Killing of A. fumigatus Conidia by Alveolar Macrophages.
 
For each
experiment, alveolar macrophages were harvested from at least
three wild-type and three X-CGD mice as previously described
(18). Briefly, mice were killed by ketamine overdose and exsan-
guinated by inferior vena cava puncture. The thoracic cavity was
opened and the trachea exposed by dissection. An 18-g angiocath
(Becton Dickinson Vascular Access, Sandy, UT) was inserted in
the trachea and the lungs were lavaged with 20 ml of prewarmed
(37
 
8
 
C) PBS containing penicillin (50 U/ml; GIBCO BRL,
Gaithersburg, MD) and streptomycin (50 
 
m
 
g/ml; GIBCO BRL)
in 1 ml vol. Viability was always 
 
.
 
95% and lavaged cells were 
 
.
 
97%
macrophages as determined by differential counts of Wright-Giemsa
stained cytospins.
Assays for macrophage-mediated killing of 
 
A. fumigatus
 
 conidia 
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were adapted from the method of Schaffner (13). Alveolar lavage
cells were pooled, centrifuged at 600 
 
g
 
, washed once with PBS,
and resuspended in RPMI 1640 containing 2 mM L-glutamine
(GIBCO BRL), 50 U/ml penicillin, 50 
 
m
 
g/ml streptomycin, and
10% fetal bovine serum (Sigma Chemical Co., St. Louis, MO) at
a concentration of 2.5 
 
3
 
 10
 
6
 
 cells/ml. Freshly isolated conidia
were suspended at a concentration of 12.5 
 
3
 
 10
 
6
 
 conidia/ml in
PBS and combined with an equal volume of macrophage cell sus-
pension (1:5 macrophage/conidia). Macrophage/conidia mixtures
were tumbled at 
 
z
 
10 rpm for 45 min at 37
 
8
 
C, layered over 2 ml
Histopaque-1119 (Sigma Chemical Co.), and centrifuged at 700 
 
g
 
for 20 min at 4
 
8
 
C. Interface cells were removed, washed once in
PBS, and resuspended at 1 
 
3
 
 10
 
5
 
 cells/ml. 1-ml aliquots were
placed in polypropylene tubes (Falcon 
 
'
 
2059; Becton Dickinson
Labware) in triplicate and incubated for 0, 6, or 20 h at 37
 
8
 
C.
Cells were lysed by addition of 9 ml distilled water containing 1%
Triton X-100 (Sigma Chemical Co.) with vortexing for 3 min.
The number of colony-forming units recovered was counted
from serial dilutions of lysates plated on Sabouraud agar and incu-
bated for 48 h at 37
 
8
 
C. Counted plates contained between 5 and
50 conidia. The number of viable conidia recovered at 6 h from
control tubes containing no macrophages was not significantly
different from the number of conidia recovered at 0 h.
 
Experimental Infection with A. fumigatus.
 
Mice were infected
with 
 
A. fumigatus
 
 conidia as previously described (15). The tra-
chea was exposed, a 24-g angiocath (Becton Dickinson Vascular
Access) was inserted, and the inoculum was instilled in 35 
 
m
 
l of
sterile saline containing 5% colloidal carbon (Eberhard Faber,
Inc., Lewisburg, TN) to allow localization of the inoculum in
each lung. The challenge dose was confirmed by both quantita-
tive culture of homogenized lung tissue obtained from at least
two wild-type mice 1–2 h after instillation and plate culture of
the inoculum suspension. As prophylaxis against secondary bacte-
rial infection, mice were given 1.25 mg ceftriaxone (Rocephin;
Hoffman-La Roche, Nutley, NJ) immediately after infection, and
again 24 h later, followed by oral tetracycline (5 mg/ml in drink-
ing water) for the remainder of the experiment. Mice were ex-
amined daily and killed by halothane overdose when symptoms
suggested advanced disease (lethargy, hunched posture, ruffled
fur, and labored respirations) or at 2–3 wk. Lungs were removed
and fixed in neutral buffered formalin for histologic examination
of paraffin-embedded sections obtained from carbon-stained re-
gions of lung. Sections were stained with hematoxylin and eosin
for assessment of pathological changes or Grocott methamine sil-
ver for assessment of hyphae. Histologic sections were analyzed in
regions containing colloidal carbon, which is a marker for regions
receiving conidia. Mice were scored as positive for 
 
Aspergillus
 
 in-
fection if they had pathological indications of disease, e.g., ab-
scesses, extensive bronchopneumonia, or inflammatory nodules,
on gross or histologic examination.
 
Administration of Sterile A. fumigatus Hyphal Cell Walls.
 
Mice were
prepared as described above except that, instead of 
 
A. fumigatus
 
conidia, 5 
 
m
 
g of sterile cell wall material isolated from 
 
A. fumiga-
tus
 
 hyphae (see below) was administered in 35 
 
m
 
l of sterile saline
containing 5% colloidal carbon. This dose was chosen after pilot
experiments demonstrated that this dose produced a mild, self-
limited, pneumonia with no mortality in wild-type mice. Higher
doses from 50 to 500 
 
m
 
g caused severe acute pulmonary inflam-
mation and occasional deaths in wild-type mice. Except where
noted, at least five mice were used per experiment. Mice were
given antibiotic prophylaxis as described above. Mice were killed
at 24 h, 72 h, 1, 3, and 6 wk by halothane overdose, and lungs
were prepared as described above for histologic examination. Pe-
ripheral blood counts were performed as described (19).
 
A. fumigatus
 
 hyphal cell walls were prepared from an overnight
culture grown on Sabouraud dextrose agar at 37
 
8
 
C. The mycelia
were scraped from a culture dish and suspended in 50 ml of PBS.
The hyphae were washed five times in 50 ml of PBS, and then
autoclaved to sterilize them. Sterilized hyphae were dried, frozen
in liquid nitrogen, and ground to a fine powder with a mortar
and pestle. The powder was washed three times in PBS, and then
sonicated for 10 min at a setting of 100 with a 50% duty cycle
(Vibra-cell; Sonics & Materials Inc., Danbury, CT). The resulting
suspension was washed with PBS and centrifuged at 15,700 
 
g
 
 to
pellet. The pellet was lyophilized, weighed, and resuspended at a
concentration of 3 mg/ml in double-distilled water. Sterile tech-
nique and sterile solutions were used throughout the procedure.
Cultures of the final hyphal preparation for bacterial and fungal
growth were negative.
 
Morphometric Quantitation of Lung Inflammatory Infiltrate. 
 
The
number of inflammatory cells (PMNs, large mononuclear cells,
and small mononuclear cells) were counted in randomly selected
alveoli containing colloidal carbon as previously described (20).
Data were expressed as number of cells per 100 alveoli. Groups
were compared using a two-tailed Student’s 
 
t
 
 test for normally
distributed data or a Mann-Whitney test for nonparametric data.
 
RNA Isolation and Northern Analysis. 
 
Lungs from untreated
wild-type and X-CGD mice were removed and frozen immedi-
ately in liquid nitrogen then stored at 
 
2
 
70
 
8
 
C. Lungs from mice
given sterile 
 
A. fumigatus
 
 hyphae were removed 24 h, 72 h, or
1 wk after treatment and stored similarly. Lung tissue was ground
to a powder with a mortar and pestle chilled with liquid nitrogen,
dissolved in Solution D (4 M guanidine thiocyanate, 25 mM so-
dium citrate, 0.5% 
 
N
 
-lauryl sarcosine, and 0.1 M 2-mercaptoeth-
anol; all from Sigma Chemical Co.) and total RNA extracted as
described (21). 10 
 
m
 
g of RNA was run on a 1% agarose/formal-
dehyde gel and transferred to Magnacharge nylon membranes
(Micron Seps Inc., Westboro, MA) according to the manufac-
turer’s instructions. Radiolabeled cDNA probes were prepared by
random priming (Prime-a-Gene kit; Promega Corp., Madison,
WI) according to the manufacturer’s instructions. The murine
IL-1
 
b
 
 cDNA was provided by Dr. Patrick Gray (Genentech,
Inc., South San Francisco, CA), the TGF
 
b
 
1
 
 cDNA by Dr. Rik
Derynck (Genentech, Inc.), and the JE (murine monocyte chemo-
tactic protein-1), KC (murine homologue of the human gro
 
a
 
gene), and TNF-
 
a
 
 cDNAs were from the American Type Cul-
ture Collection. To correct for differences in loading, the North-
ern blots were probed for 
 
b
 
-actin. Differences in expression were
quantitated by densitometry (GS-700 Densitometer; Bio Rad
Labs., Hercules, CA) and were normalized to 
 
b
 
-actin expression.
 
Results
 
Killing of A. fumigatus Conidia by Alveolar Macrophages from
X-CGD Mice.
 
To evaluate the role of phagocyte-derived
oxidants in resistance to the conidial form of 
 
A. fumigatus
 
,
we compared the ability of alveolar macrophages from
wild-type and X-CGD mice to kill conidia in vitro. No
differences were observed in the phagocytic potential of
X-CGD versus wild-type macrophages as measured by the
phagocytic index, i.e., the ratio of ingested conidia to mac-
rophages, or the percentage of macrophages phagocytosing
at least one conidia (Table 1). 6 h after phagocytosis, the 
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majority of ingested conidia in both wild-type and X-CGD
macrophages had been killed, with a similar percentage of
conidia killed in cultures containing wild-type macrophages
(86 
 
6
 
 18%) as were killed in cultures containing macro-
phages from X-CGD mice (92 
 
6
 
 10%). By 20 h of incuba-
tion, both wild-type and X-CGD mice had effected more
than a log reduction in viable conidia. However, we are
unable to draw any firm conclusion regarding macrophage
killing at this time point since control cultures containing
no macrophages also show a similar loss in viable conidia,
presumably through germination and subsequent adher-
ence and aggregation of hyphae.
 
Experimental Infection with A. fumigatus.
 
Wild-type and
X-CGD mice were challenged with 
 
A. fumigatus
 
 conidia at
doses ranging from 1 
 
3
 
 10
 
5
 
 to 48 per animal, as adminis-
tered by intratracheal instillation. No mortality was ob-
served in wild-type mice, even at the highest dose tested.
In contrast, pulmonary disease occurred in all X-CGD
mice after 
 
Aspergillus
 
 exposure, with 24 of the 28 mice dead
or moribund within 11–21 d due to progressive lung dis-
ease (Fig. 1). X-CGD mice given 1 
 
3 105 conidia devel-
oped a rapidly progressing and uniformly fatal broncho-
pneumonia with all mice dead or moribund by the fourth
day after infection, similar to what was previously observed
with exposure to 3 3 106 conidia (15). Administration of
lower doses resulted in a longer asymptomatic period and
survival of a small number of mice (Fig. 1).
Fungal cultures of lung homogenates obtained at autopsy
showed persistence of viable colony-forming units (cfu) of
A. fumigatus in 27 out of 28 X-CGD mice after respiratory
challenge (Table 2). Only one X-CGD mouse, who was
studied at 21 d after exposure to 48 spores, did not have
fungus cultured from lung tissue, although both abscesses
and chronic inflammatory lesions with rare hyphal forms
visible by silver stain were seen in lung sections prepared
from this mouse (not shown). In contrast, very few, if any,
viable A. fumigatus cfu were cultured from lungs obtained
from wild-type mice, even after 3–4 d of challenge with
1 3 105 conidia (Table 2).
Table 1. Anticonidial and Phagocytic Potential of Wild-type
and X-CGD Alveolar Macrophages
Experimental
group
Phagocytic
index
Percent
phagocytosis
Percent of
conidia killed
Wild type 2.2 6 0.3 61 6 2 86 6 18
X-CGD 2.1 6 0.4 55 613 92 6 10
Alveolar macrophages were allowed to ingest conidia for 45 min at
37°C (1:5 macrophage to conidia ratio), and then incubated an addi-
tional 6 h at 37°C. Percent killing of ingested conidia was then deter-
mined by lysing macrophages and plating in at least triplicate cultures on
Sabaroud agar. Phagocytic index (the ratio of ingested conidia to mac-
rophages) and percent phagocytosis (the percentage of macrophages in-
gesting at least one conidia) were determined by counting at least 200
cells in Wright-Giemsa stained cytospins. Data are expressed as mean 6
SD of two independent experiments using alveolar macrophages pooled
from three to five mice per experiment.
Figure 1. Survival curve of X-CGD mice receiving from 1 3 105 to
48 A. fumigatus conidia. Mice were examined daily and the percent of
mice surviving in each treatment group was plotted versus time from in-
tratracheal administration of the indicated dose of conidia (day 0). s, 1 3
105 conidia/mouse (n 5 5); ,, 7 3 103 conidia/mouse (n 5 5); n, 1 3
103 conidia/mouse (n 5 8); h, 540 conidia/mouse (n 5 5); e, 48
conidia/mouse (n 5 5).
Table 2. Culture of A. fumigatus from Lung Tissue after Intratracheal Administration of Conidia to X-CGD and Wild-type Mice*
Conidia dose
Duration of study
(days after
conidia challenge)
Wild-type mice X-CGD mice
Mean cfu‡/lung Range Mean cfu‡/lung Range
100,000 3–4 35 0–128 (n 5 6) 22,000 2,000–40,000 (n 5 4)
7,000 3–9 Not done 8,500 400–16,000 (n 5 5)
1,000 7–11 100 0–200 (n 5 2) 3,800 200–12,000 (n 5 8)
540 8–11 0 n/a (n 5 3) 870 60–4,000 (n 5 5)
48 4–21 Not done 225 0–680 (n 5 5)
*Lungs were homogenized in 1 ml PBS per lung and serial dilutions were plated on Sabouraud’s media in triplicate. Colonies were counted from
plates containing 10–50 colonies.
‡cfu detected by plate culture.211 Morgenstern et al.
In agreement with previous studies (8, 15), the histologic
appearance of lungs from wild-type mice challenged in-
tratracheally with 1 3 105 conidia and killed 3 d after in-
fection, appeared either normal or showed only a mild
peribronchial pneumonia (data not shown). No hyphae
were visible in silver-stained sections (data not shown).
Gross and histologic abnormalities after A. fumigatus
respiratory challenge were observed in the lungs of all
X-CGD mice at all doses of conidia studied. X-CGD mice
that died or were moribund within the first week after
Aspergillus challenge had similar pathology. Histologic find-
ings, which included extensive peribronchiolar and alveolar
inflammation consisting of neutrophils, necrotic debris,
and edema, were similar to that previously described for
X-CGD mice challenged with 3 3 106 conidia (not shown)
(15). In X-CGD mice that survived beyond 1 wk, chronic
inflammatory changes became more evident. Areas of al-
most complete neutrophil consolidation surrounded by a
more diffuse mononuclear cell infiltrate and edema were a
common finding (Fig. 2 a), as was the formation of well-
circumscribed abscesses (not shown). Intact hyphae, as vi-
sualized by silver staining, were detected in all X-CGD
mice challenged with Aspergillus. Regions with an exten-
sive neutrophil infiltrate typically contained numerous hy-
Figure 2. Pulmonary disease in X-CGD mice after administration of
A. fumigatus conidia. (a) Lung tissue obtained 11 d after challenge with
540 A. fumigatus conidia and stained with hematoxylin and eosin. Note
areas of neutrophil inflammation surrounded by mononuclear cells (origi-
nal magnification of 100). (b) Grocott methamine stain of lung from
X-CGD mouse with neutrophil inflammation; note branching filamen-
tous hyphae (original magnification of 100). (c) Grocott methamine silver
staining of the same tissue shown in a with no visible hyphae (original
magnification of 100). (d) Lung tissue obtained 21 d after challenge with
48 conidia and stained with hematoxylin and eosin. Low power view of a
representative inflammatory lesion showing nodular region of inflamma-
tion and destruction of underlying lung tissue (original magnification of
100). (e) Higher power view of chronic inflammatory lesion consisting of
neutrophils, epithelioid macrophages, and giant cells (original magnifica-
tion of 400).212 Aspergillosis in X-linked Chronic Granulomatous Disease Mice
phae (Fig. 2 b), while areas of chronic inflammation had
few hyphae (not shown). However, occasional regions with
numerous focal collections of neutrophils did not contain
detectable hyphae (Fig. 2 c). In X-CGD mice who survived
for more than 2 wk after Aspergillus challenge, chronic in-
flammatory lesions were typically distributed in a nodular
pattern and were comprised largely of mononuclear cells
(Fig. 2 d) along with other cell types frequently associated
with granulomatous inflammation including large, highly
vacuolated macrophages (foam cells; not shown) and giant
cells (Fig. 2 e). Neutrophils were often present in the cen-
ters of these nodules (Fig. 2 e), and occasionally, necrotic
debris (not shown).
Granulomatous Inflammation in X-CGD Mice Elicited by
Sterile A. fumigatus Hyphae. The observation of intense
acute and chronic inflammation in X-CGD mice with no
or small numbers of hyphae (Fig. 2, a and c) led us to spec-
ulate that the defect in phagocyte oxidant production was
associated with a prolonged inflammatory response that was
independent of active fungal infection. To separate the ef-
fects of persistent infection in X-CGD mice from the in-
flammatory response to Aspergillus, we administered sterile
hyphal fragments to wild-type and X-CGD mice.
Striking differences in the appearance of the alveolar in-
flammatory infiltrate in wild-type versus X-CGD mice
were evident even during the first 72 h after instillation of
hyphae. At 24 h, an intense neutrophil alveolar infiltrate
was seen in X-CGD mice, with foci of neutrophils often
found in tight clusters around an eosinophilic center, with
many cells assuming a spindle-shaped orientation towards
the center of the inflammatory focus (Fig. 3 a). In contrast,
in wild-type mice, the predominantly neutrophilic inflam-
matory infiltrate was diffusely scattered among alveoli with-
out this focal pattern (Fig. 3 b). By 72 h, increased numbers
of large mononuclear cells, debris, and a fibrinous exudate
were seen in wild-type lung samples, again in a diffuse dis-
tribution (not shown). In X-CGD lung, focal accumula-
tions of neutrophils were still numerous and were often
surrounded by mononuclear cells (not shown).
Figure 3. Lung inflammation in wild-type mice and X-CGD mice 24 h after challenge with sterile A. fumigatus hyphae. Lung tissue was obtained 24 h
after intratracheal administration of 5 mg of sterile hyphae and staining of representative sections with hematoxylin and eosin. (a) X-CGD lung with pneu-
monia and focal centers of neutrophil accumulation (original magnification of 400). (b) Lung from a wild-type mouse with comparatively mild, diffuse
neutrophil infiltrate. (original magnification of 400).
Figure 4. Morphometric analysis of lung sections 24 and 72 h after
challenge with sterile A. fumigatus hyphae. Lung tissue was obtained either
24 or 72 h after intratracheal administration of 5 mg of sterile hyphae. 100
randomly selected alveoli containing carbon were scored for numbers of
neutrophils, large mononuclear cells, and small mononuclear cells. Data are
expressed as mean 6 SD. Open bars, wild-type mice; filled bars, X-CGD
mice. *, significantly different from wild type (P ,0.0005, t test); ‡, signif-
icantly different from wild type (P ,0.05, t test); §, significantly different
from wild type (P ,0.005, t test).
Morphometric analysis of the inflammatory cell infiltrate
elicited by intratracheal administration of sterile hyphal
fragments was also performed to obtain a quantitative mea-
sure of the differences between wild-type and X-CGD213 Morgenstern et al.
mice. At both 24 and 72 h, the neutrophils were the pre-
dominant cell type in both X-CGD and wild-type alveoli
(Fig. 4). However, X-CGD mice had almost five times the
amount of neutrophils as wild-type controls. The number
of mononuclear cells was also significantly higher (almost
double) in X-CGD mice compared to wild-type mice 72 h
after administration of hyphae (Fig. 4). No differences in
the peripheral leukocyte counts were observed between
wild-type and X-CGD mice at either of these time points
(data not shown).
One week after administration of 5 mg of sterile hyphal
fragments, 11 out of 13 wild-type mice still had evidence
of a mild, diffuse alveolar pneumonia, consisting of neu-
trophils and mononuclear cells (not shown). In two wild-
type mice, a more severe chronic inflammatory response
developed, characterized by extensive infiltration of alveoli
with large mononuclear cells and a fibrinous exudate (not
shown). In contrast, at 1 wk, 8 out of 8 X-CGD mice
were found to have a distinctive granuloma-like inflamma-
tory infiltrate consisting of neutrophil microabscesses sur-
rounded by large mononuclear cells with an epithelioid
morphology (not shown). By 21 d, the contrast between
wild-type and X-CGD mice was even more striking. The
pneumonia in 3 out of 3 wild-type mice had almost en-
tirely resolved (Fig. 5 a), whereas 3 out of 3 X-CGD mice
still had numerous inflammatory nodules (Fig. 5 b) which
often become confluent (Fig. 5 c). These foci continued to
show a characteristic granuloma-like structure, with a cen-
tral area of neutrophils surrounded by epithelioid mononu-
clear cells (Fig. 5 d). Lungs obtained from 3 of 3 X-CGD
mice 6 wk after administration of sterile hyphal fragments
showed persistence of these inflammatory lesions. No evi-
dence of hyphal growth was evident in Grocott methamine
silver–stained sections (not shown), and cultures of lungs
from X-CGD mice killed at 1 wk showed no growth of
fungi and grew similar numbers of bacteria to that observed
in wild-type mice (,1 3 104 cfu/lung).
Expression of Cytokines in Lungs after Intratracheal Adminis-
tration of Sterile A. fumigatus Hyphae. To determine if the
differences in the inflammatory response to sterilized A. fu-
migatus hyphae between X-CGD and wild-type mice ob-
served by histologic examination were associated with dif-
Figure 5. Inflammatory response in wild-type and X-CGD mice lungs 21 d after challenge with sterile A. fumigatus hyphae. Lung tissue was obtained
21 d after intratracheal administration of 5 mg of sterile hyphae and stained with hematoxylin and eosin. (a) Representative section of lung from a wild-type
mouse. Inflammation has largely resolved, although some residual edema and peribronchiolar inflammation remain (original magnification of 100). (b)
Lung from X-CGD mouse with scattered nodular inflammatory foci (original magnification of 100). (c) Lung from X-CGD mouse with almost complete
consolidation and destruction of lung parenchyma (original magnification of 100). (d) Higher power of area in 6 b, showing central neutrophil microab-
scess and surrounding epithelioid cells (original magnification of 400).214 Aspergillosis in X-linked Chronic Granulomatous Disease Mice
ferences in cytokine expression, we examined Northern
blots of total lung RNA from X-CGD and wild-type mice
using probes for several proinflammatory mediators, as well
as TGFb1, a potent antiinflammatory cytokine (22).
Of the cytokines examined, IL-1b, TNF-a, JE, and KC
showed very low, if any, levels of expression in untreated
mice, with no significant differences observed between
X-CGD and wild-type mice (Figs. 6 and 7). TGFb1 ex-
pression was detectable in untreated mice at similar levels in
wild type and X-CGD (Figs. 6 and 7). The most striking
differences in mRNA expression after instillation of hyphae
were observed with the proinflammatory cytokines IL-1b
and TNF-a. Although markedly increased in both X-CGD
and wild-type mice by 24 h after instillation, the expression
of IL-1b and TNF-a in X-CGD mice was nearly 5- and
8.5-fold, respectively, higher than levels seen in wild-type
animals (Fig. 7, a and b). By 72 h, expression of both cy-
tokine mRNAs had dropped nearly to baseline levels in
wild-type mice, while expression in X-CGD mice was
even higher than at 24 h and remained persistently elevated
for at least a week (Fig. 7, a and b). In addition, we also ex-
amined expression of two chemokines, KC and JE. KC,
the murine groa homologue, binds to the murine orphan
IL-8 receptor and is a potent neutrophil chemoattractant
and activator (23), while JE, the murine homologue of
monocyte chemoattractant protein-1 has similar activity for
monocytes (24). Expression of KC and JE peaked at 24 h in
both wild-type and X-CGD mice, and then declined (Fig.
6). Expression of both KC (Fig. 7 c) and JE (data not
shown) were significantly higher at 24 h in X-CGD mice
relative to wild-type controls, and KC remained signifi-
cantly elevated in X-CGD versus wild-type mice at 72 h
and 1 wk (three- to fivefold, respectively). TGFb1 was sig-
nificantly elevated in X-CGD mice relative to wild-type
controls at 24 h, but not at later time points (Fig. 7 d).
Discussion
In this study, we have investigated the host response to
A. fumigatus in mice that lack phagocyte respiratory burst
oxidase activity due to targeted disruption in the X-linked
gene for gp91phox. A. fumigatus is an opportunistic fungal
pathogen that accounts for z15% of infections that occur in
patients with CGD, typically causing what can be life-threat-
ening pneumonias (25). Previous work in our laboratory
has demonstrated that X-CGD mice develop an invasive,
necrotizing bronchopneumonia after respiratory challenge
with large numbers of A. fumigatus conidia (15). We now
show that exposure to as few as 50 conidia can establish pul-
monary infection in X-CGD mice. Furthermore, adminis-
tration of sterilized Aspergillus hyphae produce chronic
granulomatous inflammation in X-CGD mice, indicating
that viable organisms are not a prerequisite for the develop-
ment of chronic inflammatory lesions in CGD.
That even a small number of A. fumigatus conidia appear
to be sufficient to cause infection in X-CGD mice illus-
Figure 6. Northern analysis of total lung RNA in wild-type and X-CGD
mice receiving sterile A. fumigatus hyphae. Lung tissue was obtained from
wild-type (WT) and X-CGD (CGD) mice which were untreated (Con-
trol) or given 5 mg of sterile hyphal fragments by intratracheal administra-
tion. Mice given hyphal fragments were killed either at 24 h, 72 h, or
1 wk after instillation and the lungs removed and total RNA isolated as
described in Materials and Methods. Blots were sequentially probed with
the indicated cDNAs.
Figure 7. Densitometric analysis of cytokine expression in wild-type
and X-CGD mice receiving A. fumigatus hyphae. Autoradiographs were
scanned and optical density calculated after background subtraction. Opti-
cal density was expressed as arbitrary density units and then normalized to
b-actin expression. Data expressed as mean 6 SD. (a) IL1b; (b) TNF-a;
(c) KC; (d) TGFb1. Open bars, wild-type mice; filled bars, X-CGD mice. *,
significantly different from wild type (P ,0.05, Mann-Whitney U test);
‡, significantly different from wild type (P ,0.05, t test); §, significantly
different from wild type (P ,0.0005, t test); i, significantly different from
wild type (P ,0.005, t test).215 Morgenstern et al.
trates the importance of respiratory burst oxidants in the
host defense against this organism. We found that alveolar
macrophages obtained from X-CGD mice ingested and
killed conidia as efficiently as wild-type alveolar macrophages,
consistent with previous studies showing that macrophage
anticonidial activity is due to nonoxidative processes (13,
14). However, although X-CGD alveolar macrophages
may function effectively as the first line of defense, it is
likely that some conidia resist intracellular killing or are not
ingested before germination. Phagocytosis of conidia in vi-
tro by wild-type macrophages has been shown to be rapid
and efficient both in the presence and absence of opsonins,
but some manage to evade phagocytosis (11, 26), perhaps
due to the release of soluble antiphagocytic substances from
conidia (27). Hyphae germinating from conidia that escape
macrophage-mediated killing would be efficiently killed by
neutrophils in wild-type mice by oxidative mechanisms
(11, 12) that are deficient in CGD. We found that viable
fungus persisted for days to weeks in X-CGD mice, even
after exposure to small numbers of conidia, and intact hy-
phae were frequently seen by silver-staining of lung tissue.
As has been pointed out by others, precise quantitation of
the load of viable Aspergillus is difficult since it has no re-
producible infective unit (28). Individual colonies on plate
culture can arise from either conidia, small pieces of hy-
phae, or mycelial clumps.
After exposure to small numbers of conidia, X-CGD
mice survived for up to 21 d, which may simply represent a
slower progression of infection or may reflect some degree
of nonoxidative antihyphal activity, as suggested by the
presence of abscesses containing few, or no, hyphae. One
report has described a compensatory enhancement of non-
oxidative antihyphal activity in monocytes from human
CGD patients (29). This activity was found in fractions en-
riched for cytoplasmic granules, did not require exogenous
peroxide or halide, and was inhibited by polyanions, sug-
gesting granule-associated cationic proteins as potential me-
diators of this activity. Abscess formation may also help to
slow the invasion of surrounding tissue by walling off
growing hyphae.
It is important to note that differences in nonoxidative
antimicrobial activity have been noted between human and
murine phagocytes, so that results from these murine stud-
ies cannot necessarily be extrapolated to patients. For ex-
ample, murine neutrophils lack defensins (30), a class of
cationic antimicrobial peptides, but appear to have a higher
capacity to generate nitric oxide (31). Nevertheless, our
data suggest that exposure even to low doses of A. fumigatus
spores may pose a serious risk of infection in X-CGD pa-
tients.
Although bacterial and fungal infections are an important
component of the clinical syndrome associated with CGD,
complications arising from granulomatous inflammation
can also cause considerable morbidity (4). It has long been
postulated that the granulomatous manifestations of this
disorder reflect an intrinsic defect in the resolution of in-
flammatory responses (4). However, a requisite role of the
respiratory burst in inflammation outside of its function in
microbial killing has yet to be clearly defined. The produc-
tion of superoxide results in an increase in pH within the
phagocytic vacuole that may be important for optimizing
the digestive activity of granule proteins released into this
compartment (6, 32). Abnormal vacuolar pH regulation in
CGD phagocytes could hence lead to defective digestion of
ingested microbial products or debris and a prolongation of
the inflammatory process. Respiratory burst oxidants have
also been implicated in the inactivation of chemoattractant
factors (33, 34) and in the inactivation of proteinase inhibi-
tors and activation of latent metalloproteinases (35). It has
also been noted that oxygen radicals satisfy many of the re-
quirements for second messengers (36, 37), and that some
transcription factors appear to be regulated by their redox
state (38), suggesting that oxidants may have direct effects
on gene expression. For example, oxidant stress may up-
regulate interleukin-8 expression (39).
Abnormal inflammatory responses in response to injury
have previously been described in both murine and human
CGD. In the initial response to intraperitoneal injection
of sterile thioglycollate, both gp91phox2/2 (X-CGD) and
p47phox2/2 (autosomal CGD) mice exhibit an initial increase
in the steady-state number of peritoneal exudate neutrophils
that is ztwofold higher than that observed for wild-type
mice (15, 40). In X-CGD mice, the percentage of exudate
neutrophils declines with kinetics that are comparable to
those observed in wild-type mice, but absolute neutrophil
numbers remain persistently elevated over levels seen in
exudate obtained from wild-type controls (15). Similarly,
in human X-CGD patients, the percentage of neutrophils
measured with the Rebuck skin window technique is ab-
normally elevated from 8 to at least 24 h after abrasion (41).
Persistent pulmonary inflammation has been reported in a
CGD patient after infection with A. fumigatus. In this case,
amphotericin treatment of biopsy proven A. fumigatus pro-
duced an initial clinical response. Pulmonary function sub-
sequently deteriorated, and a second lung biopsy showed
evidence of a sterile interstitial pneumonitis, which was suc-
cessfully treated with corticosteroids (42). However, chronic
inflammatory changes have not been observed in the lungs
of X-CGD mice surviving a single episode of either gram-
positive or gram-negative pneumonia (Dinauer, M., M. Gif-
ford, and C. Doerschuk, manuscript in preparation). These
studies suggest that inflammatory responses to only some
inciting stimuli may be abnormal in CGD.
In the present study, we found that pulmonary adminis-
tration of sterilized A. fumigatus hyphae produced an altered
inflammatory response in X-CGD mice relative to wild-
type controls. This is the first experimental evidence that
the absence of phagocyte respiratory burst oxidants can be
associated with the development of chronic inflammatory
lesions even without an inciting bacterial infection. Our
studies also suggest that the underlying mechanisms respon-
sible for the pathologic response to sterilized hyphae in
X-CGD mice include aberrant production of proinflam-
matory cytokines. In wild-type mice, sterilized hyphae
produced a self-limited pneumonia, with development of a
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of IL-1b, TNF-a, and the chemokine KC, a neutrophil
chemoattractant (43) during the first few days of the re-
sponse. In X-CGD mice, these early responses were mark-
edly exaggerated, and expression of IL-1b, TNF-a, and
KC remained elevated one week after administration of
sterilized hyphae. At one week after hyphae administration,
X-CGD mice had developed a granulomatous, neutrophil-
containing alveolar infiltrate that persisted for at least 6 wk.
Expression of TGFb1, a potent antiinflammatory cytokine
(22), was similar in both wild-type and X-CGD mice, sug-
gesting that the defect in the inflammatory response is not due
to an inability to generate appropriate antiinflammatory re-
sponses. However, the net balance of cytokine expression
in the lungs of X-CGD mice in response to sterilized hy-
phae appears to be tipped towards the proinflammatory side
of the equation, which could promote a continued inflam-
matory response rather than its resolution.
A prolonged period of neutrophil recruitment and in-
flammation could also be indicative of the relative persis-
tence of A. fumigatus cell wall material as an inflammatory
stimulus in X-CGD mice compared with thioglycollate,
localized skin injury, or bacteria. Chitin and glucans are
major structural components found in Aspergillus hyphae
(44) and have also been shown to potentiate macrophage
activation (45, 46). Mechanisms which eliminate fungal cell
wall components in vivo are not well understood, but may
be dependent on appropriate pH regulation of the phago-
cytic vacuole or still undefined processes that require an in-
tact respiratory burst. However, it is not clear how a de-
layed digestion of fungal material in X-CGD could explain
the marked increase in inflammatory cell numbers and cy-
tokine expression observed during the early phases of the
response in X-CGD mice.
A final comment relates to the chronic pulmonary le-
sions elicited in X-CGD mice by respiratory exposure to
A. fumigatus, which are a mixture of neutrophilic and gran-
ulomatous inflammation. Granulomas have classically been
loosely grouped into two major types, immune or hyper-
sensitivity granulomas which are characterized by accumu-
lation of epithelioid cells, lymphocytes, and plasma cells in
response to a persistent antigen that induces a delayed-type
hypersensitivity response, and foreign body granulomas which
typically lack lymphocytes and are formed in response to
nonimmunologically active, but persistent agents (47). The
chronic lesions seen in X-CGD mice, although resembling
granulomas in certain aspects such as persistence and the ac-
cumulation of epithelioid macrophages, are atypical in that
they frequently include foci of neutrophils and debris, and
are hence perhaps better described as granulomatous mi-
croabscesses. Pathology similar to that observed in X-CGD
mice has previously been described in patients with CGD,
particularly in association with fungal infections (2, 5).
In summary, our data demonstrate that infection of
X-CGD mice with A. fumigatus can occur even with ad-
ministration of as few as 50 conidia via the respiratory
route, consistent with the high frequency of A. fumigatus
infection seen in CGD patients. Administration of either
low doses of conidia or sterile fungal cell walls to X-CGD
mice produced chronic lung inflammation, often with gran-
ulomatous features. An understanding of how sterilized hy-
phal fragments produce chronic inflammatory lesions in the
X-CGD mouse model may shed light on why chronic in-
flammation is a frequent complication of human CGD and
the role played by respiratory burst oxidants outside of its
function in host defense. Future studies will focus on iden-
tifying fungal mediators of chronic inflammation, clearance
of fungal debris, and further investigation on the role of pro-
inflammatory and antiinflammatory cytokines in response to
pulmonary injury in X-CGD mice. This model of Aspergillus
infection and chronic inflammation should also provide an
excellent means to test the efficacy of various antifungal, an-
tiinflammatory, and immunomodulatory strategies in treat-
ing CGD.
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